Search

everythinglearnresearchcommunity

for

Search:↓

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Fetal environments contain various chemicals that may disrupt hormones.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Liposomal carriers can improve tissue regeneration by stabilizing and retaining growth factors.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Essential oils in cosmetics can offer benefits but may cause allergies and should be used carefully.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Smaller nanoparticles penetrate skin better, especially through hair follicles.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Apoptosis is crucial for healthy skin and treating skin diseases.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.